Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma

BACKGROUNDS: The pandemic of overweight and obesity (quantified by body mass index (BMI) ≥ 25) has rapidly raised the patient number of non-alcoholic fatty hepatocellular carcinoma (HCC), and several clinical trials have shown that BMI is associated with the prognosis of HCC. However, whether overwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ning-Ning, Du, Xi-Yue, Zhang, Yue-Shan, Jiao, Zhi-Kai, Wu, Xiao-Hui, Yang, Bao-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877416/
https://www.ncbi.nlm.nih.gov/pubmed/36714595
http://dx.doi.org/10.3389/fendo.2022.1061091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877416/
https://www.ncbi.nlm.nih.gov/pubmed/36714595
http://dx.doi.org/10.3389/fendo.2022.1061091

Ejemplares similares